Odyssey Therapeutics raises $304M in IPO to fuel autoimmune pipeline - Axios
Odyssey Therapeutics raises $304M in IPO to fuel autoimmune pipeline Axios
ORIGINAL SOURCE →via IPO News (GN)
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · finance
- [FINANCE] Three Mexican issuers tap cross-border market
- [FINANCE] Trade Desk expects Q2 revenue at least $750M while targeting full-year 2026 adjusted EBITDA margin at least 40%
- [FINANCE] Earnings call transcript: Grindr Q1 2026 revenue beats forecast, stock rises
- [FINANCE] Earnings call transcript: Jamieson Wellness Q1 2026 reports strong EPS growth
- [FINANCE] Earnings call transcript: Synaptics beats Q3 2026 forecasts with strong IoT growth
- [FINANCE] Earnings call transcript: AMN Healthcare Q1 2026 earnings beat expectations